Skip to content

Reliability of EEG, ERP and eye tracking measurements in infants

Reliability of EEG, ERP and eye tracking measurements in infants - Reliability study in infants

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON40656
Enrollment
75
Registered
2014-06-16
Start date
2014-08-13
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

n.v.t. n.v.t.

Interventions

None listed

Sponsors

Universiteit Utrecht
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: • Age 10 months old (± 4 weeks; at time of testing) • Born fullterm (>37)

Exclusion criteria

Exclusion criteria: • Infant was premature (pre 37 weeks) • Infant is looked after by the state (e.g. foster care), or other situation in which neither birth parent is involved in the infant*s care. • Presence of known significant uncorrected vision or hearing impairment in infant (reported to parent by a doctor or health professional) • Presence of known significant developmental or medical condition in infant likely to affect brain development or infant*s ability to participate in the study (e.g. Cerebral Palsy, Down*s syndrome, cystic fibrosis; reported to parent by a doctor or health professional)

Design outcomes

Primary

MeasureTime frame
Our evaluation of the test-retest reliability of measures of brain development will be based on the following outcomes: - ERP peaks related to face processing in infants, specifically the amplitude and latency of the so-called N290 peak, in response to photographs of faces with different emotional expressions (emotional face task). - Background EEG, as reflected in power in specific frequency bands in the EEG, especially gamma power, to social and nonsocial film videos (background EEG task) - Length and number of visual fixations to stimuli that test different stages of attention (gap/overlap task).

Secondary

MeasureTime frame
None

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)